{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:45:45Z","timestamp":1772822745218,"version":"3.50.1"},"reference-count":0,"publisher":"ALUNA","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiadomo\u015bci Lekarskie"],"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Aims: This study aims to compare the intensity of the pain, medication requirements and the evolution of symptoms of neuropathic pain patients with or without\u2002COVID\u201119 infection and to determine whether the severity of the infection influenced these variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>Materials and methods: In all, 400 adults with chronic neuropathic pain (\u22653months duration) were included-200 positive and 200 negative\u2002for SARS\u2011CoV\u20112. Baseline demographic and clinical characteristics were comparable between groups (age, sex, BMI, comorbidities, pain duration; all\u2002p&gt;0.22) to meaningful outcome comparison. Pain severity, analgesic consumption, pain course and symptom deterioration were assessed pre-\/post-COVID\u201119 or\u2002similar follow-up for the controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Results: In COVID\u2011positive group score values raised from 4.6 \u00b1 1.1 to 7.7 \u00b1 1.4 (p&lt;0.05), at a more significant extent in women (4.7-8.2, p&lt;0.01) as in diabetic patients (4.6-8.1, p&lt;0.001). The COVID-negative group had\u2002no significant change (4.2-4.3, p =0.42). Post-COVID, 72% of infected patients\u2002needed more analgesics and 65% of them other drugs, vs. 15% and 12%, respectively, in the negative group p&lt;0.001. Pain curves trajectories evidenced steeper increments in COVID\u2011positive (85% vs. 25% in severe vs. mild COVID-19 worsening, p&lt;0.001, revealing a directly related pain severity to\u2002the infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Conclusion: SARS\u2011CoV\u20112 infection is an aetiologic factor that independently leads to a substantial worsening of chronic neuropathic pain, an increase in\u2002analgesic needs, and a more severe symptom burden. The impact is most pronounced among women, diabetic\u2002patients and those with severe COVID\u201119. These results emphasize the importance of proactive pain management\u2002approaches and longitudinal tracking in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.36740\/wlek\/216216","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:08:07Z","timestamp":1772802487000},"page":"123-129","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 aggravates well tolerated spinal cord injury- related neuropathic pain"],"prefix":"10.36740","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1868-1744","authenticated-orcid":false,"given":"Mohammed K.","family":"Al-Chlaihawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1406-6150","authenticated-orcid":false,"given":"Akeel Abd Uljaleel","family":"Qyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5364-8220","authenticated-orcid":false,"given":"Muntadher","family":"Zyara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-2218","authenticated-orcid":false,"given":"Salim","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2026,1,30]]},"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"link":[{"URL":"https:\/\/www.wiadomoscilekarskie.pl\/pdf-216216-136049","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wiadomoscilekarskie.pl\/pdf-216216-136049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:08:13Z","timestamp":1772802493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wiadomoscilekarskie.pl\/COVID-19-aggravates-well-tolerated-spinal-cord-injury-related-neuropathic-pain,216216,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["216216"],"URL":"https:\/\/doi.org\/10.36740\/wlek\/216216","relation":{},"ISSN":["0043-5147","2719-342X"],"issn-type":[{"value":"0043-5147","type":"print"},{"value":"2719-342X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}